Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Loeffler

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Brain : a Journal of Neurology|October 29, 2024
Supraspinal contributions to defective antagonistic inhibition and freezing of gait in Parkinson's diseasePhilipp Klocke, Moritz A Loeffler, Hannah Muessler, et al.
International Immunopharmacology|October 3, 2012
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicityLynnae M Smith, Andrea C Klaver, Mary P Coffey, et al.
Microbial Pathogenesis|August 18, 2004
Characterization of dopamine-depleting activity of Nocardia asteroides strain GUH-2 culture filtrate on PC12 cellsDavid A Loeffler, Dianne M Camp, Shirley Qu, et al.
Clinical Neuropharmacology|August 1, 1994
Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidationD A Loeffler, A J DeMaggio, P L Juneau, et al.
Journal of Neuroinflammation|June 9, 2009
Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's diseaseDianne M Camp, David A Loeffler, Diane M Farrah, et al.
Journal of Neuroscience Methods|January 26, 2010
Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific bindingAndrea C Klaver, Lynnae M Patrias, Mary P Coffey, et al.
Plos One|January 4, 2013
α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controlsLynnae M Smith, Mya C Schiess, Mary P Coffey, et al.
Frontiers in Aging Neuroscience|April 20, 2017
Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated <i>LRRK2</i> Gene MutationsDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Epidemiology and Infection|October 15, 2010
Prevalence of and risk factors for MRSA carriage in companion animals: a survey of dogs, cats and horsesA Loeffler, D U Pfeiffer, J A Lindsay, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 4, 2015
CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutationsDavid A Loeffler, Lynnae M Smith, Mary P Coffey, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Brain : a Journal of Neurology|October 29, 2024
Supraspinal contributions to defective antagonistic inhibition and freezing of gait in Parkinson's diseasePhilipp Klocke, Moritz A Loeffler, Hannah Muessler, et al.
International Immunopharmacology|October 3, 2012
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicityLynnae M Smith, Andrea C Klaver, Mary P Coffey, et al.
Microbial Pathogenesis|August 18, 2004
Characterization of dopamine-depleting activity of Nocardia asteroides strain GUH-2 culture filtrate on PC12 cellsDavid A Loeffler, Dianne M Camp, Shirley Qu, et al.
Clinical Neuropharmacology|August 1, 1994
Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidationD A Loeffler, A J DeMaggio, P L Juneau, et al.
Journal of Neuroinflammation|June 9, 2009
Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's diseaseDianne M Camp, David A Loeffler, Diane M Farrah, et al.
Journal of Neuroscience Methods|January 26, 2010
Measurement of anti-Abeta1-42 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific bindingAndrea C Klaver, Lynnae M Patrias, Mary P Coffey, et al.
Plos One|January 4, 2013
α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controlsLynnae M Smith, Mya C Schiess, Mary P Coffey, et al.
Frontiers in Aging Neuroscience|April 20, 2017
Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated <i>LRRK2</i> Gene MutationsDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Epidemiology and Infection|October 15, 2010
Prevalence of and risk factors for MRSA carriage in companion animals: a survey of dogs, cats and horsesA Loeffler, D U Pfeiffer, J A Lindsay, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 4, 2015
CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutationsDavid A Loeffler, Lynnae M Smith, Mary P Coffey, et al.
Pageof 12